Highlights

Highlights

Select a year

28 Februāris 2017

On 1 March the newly established European Reference Networks (ERNs) will start their work. ERNs are unique and innovative cross-border cooperation platforms between specialists for the diagnosis and treatment of rare or low prevalence complex diseases.

27 Februāris 2017

Today, in Brussels, Member States and regional representatives, healthcare service providers, public and private investors, economists, and practice innovators, participate in a Seminar on strategic investments for the future of healthcare, organised by the European Commission.

24 Februāris 2017

Outbreak preparedness and response to terrorist attacks on the agenda

23 Februāris 2017

EU Health Award 2016 helps NGOs continue the fight against Antimicrobial Resistance

22 Februāris 2017

Healthy food in schools: European Commission and Maltese Presidency present valuable new resource for public procurement authorities in Member States

16 Februāris 2017

The Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) confirms that exposure to UV-C lamps can cause skin and eye problems, but that more data is needed on long-term exposure to establish whether it can cause cancer.

15 Februāris 2017

The partners of the Cancer Control Joint Action (CANCON), co-financed by the EU Health Programme, have presented key results from this three-year project to an audience of EU and national policy makers, stakeholders and partners.

09 Februāris 2017

The newly appointed Expert Panel on Effective Ways of Investing in Health recently held its first Plenary Meeting in Brussels on 24 January 2017 and will now begin work on three new Opinions. Prof. Jan De Maeseneer, chair of the Expert Panel and Head of Department of Family Medicine and Primary Health Care at Ghent University, explains the Panel's role, work and impact.

09 Februāris 2017

The implementation report on the 2003 Council Recommendation on cancer screening, published today, reveals a steep rise in national screening programmes for breast, cervical and colorectal cancer. The report also includes a set of essential indicators to document the quality of screenings.

Pages